Association between Inflammatory Markers and Clinical and Metabolic Risk Factors for Cardiovascular Diseases
By: Inga Stuķēna, Andrejs Kalvelis, Guntis Bahs, Uldis Teibe, Pēteris Tretjakovs and Aivars Lejnieks
Open Access
|Nov 2009References
- Alber, H.F., Wanitschek, M.M., de Waha, S., Ladurner, A., Suessenbacher, A., Dorler, J., Dichtl, W., Frick, M., Ulmer, H., Pachinger, O., Weidinger, F. (2008). High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.,(6), 372-380.
- Alberti, K.G.M., Zimmet, P., Shaw, J. (2005). The metabolic syndrome — a new world wide definition.,, 1059-1062.
- Berg, A.H., Scherer, P.E. (2005). Adipose tissue, inflammation, and cardiovascular disease.,, 939-949.
- Bilgili, S.C.A., Dogan, A., Karaca, B. (2008). Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients.,(1), 63-68.
- Bonora, E., Targher, G., Alberiche, M., Bonadonna, R.C., Saggiani, F., Zenere, M.B., Monauni, T., Muggeo, M. (2000). Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity.,(1), 57-63.
- Caglayan, E.C., Blaschke, F., Takata, Y., Hsueh, W.A. (2005). Metabolic syndrome — interdependence of the cardiovascular and metabolic pathways.,, 135-142.
- Calabro, P., Limongelli, G., Pacileo, G., Di Salvo, G., Golino, P. (2008). The role of adiposity as a determinant of an inflammatory milieu.,(5), 450-460.
- Calabro, P., Yeh, E.T.H. (2008). Intra-abdominal adiposity, inflammation, and cardiovascular risk: New insight into global cardiometabolic risk.,, 32-38.
- El-Menyar, A.A. (2008). Cytokines and coronary artery disease: The state of the art.,(2), 139-151.
- Espinola-Klein, Ch., Rupprecht, H.J., Bickel, Ch., Lackner, K., Genth-Zotz, S., Post, F., Munzel, T., Blankenberg, S. (2008). Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome.,, 278-284.
- Florentin, M., Liberopoulus, E.N., Wierzbicki, A.S., Mikhailidis, D.P. (2008). Multiple actions of high-density lipoprotein.,, 370-378.
- Fuster, V., Sanz, J. (2008). Atherothrombosis: Past, present and future.,, spec. ed., 51-54.
- Gimeno, R.E., Klaman, L.D. (2005). Adipose tissue as an active endocrine organ: Recent advances.,, 122-128.
- Ikonomidis, I., Stamatelopoulos, K., Lekakis, J., Vamvakou, G.D., Kremastinos, D.Th. (2008). Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease.,, 3-11.
- Kahn, R., Buse, J., Ferrannini, E., Stern, M. (2005). The metabolic syndrome: Time for a critical cppraisal.,(9), 2289-2304.
- Khera, A., Mc Guire, D.K., Murphy, A.S., Stanek, H.S., Das, S.R., Vongpatanasin, W., Wians, F.H., Jr, Grundy, S.M., Lemos, J.A. (2005). Race and gender differences in C-reactive protein levels.,(3), 464-469.
- Lago, F., Diequez, C., Gomez-Reino, J., Gualillo, O. (2007). Adipokines as emerging mediators of immune response and inflammation.,(12), 716-725.
- Matsuzawa, Y. (2006). The metabolic syndrome and adipocytokines.,, 2917-2921.
- Miles, E.A., Rees, D., Banerjee, T., Cazzola, R., Lewis, S., Wood, R., Oates, R., Tallant, A., Cestaro, B., Yaqoob, P., Wahle, K.W., Calder, P.C. (2008). Age related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations.,, 298-305.
- Nilson, J. (2005). CRP-marker or marker of cardiovascular disease?,, 1527-1528.
- Pi-Sunyer, F.X. (2006). The relation of adipose tissue to cardiometabolic risk., 8 (Suppl. 4), S14-S23.
- Rosenson, R.S. (2005). New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.,(5), 241-280.
- Ross, R. (1999). Atherosclerosis — An inflammatory disease.,, 115-126.
- Saltevo, J., Vanhala, M., Kautiainen, H., Kumpusalo, F., Laakso, M. (2008). Gender difference in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in metabolic syndrome: A population-based study.,(6), 747-750.
- Taeye, B.D., Smith, L.H., Vaughan, D.E. (2005). Plasminogen activator inhibitor-1 a common denominator in obesity, diabetes and cardiovascular disease.,, 149-154.
- Virani, S.S., Polsani, V.R., Nambi, V. (2008). Novel markers of inflammation in atherosclerosis.,(2), 164-170.
DOI: https://doi.org/10.2478/v10046-009-0041-6 | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Language: English
Page range: 204 - 209
Published on: Nov 6, 2009
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2009 Inga Stuķēna, Andrejs Kalvelis, Guntis Bahs, Uldis Teibe, Pēteris Tretjakovs, Aivars Lejnieks, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.